In Situ Deployment of Engineered Extracellular Vesicles into the Tumor Niche via Myeloid-Derived Suppressor Cells.
Duarte-Sanmiguel S, Panic A, Dodd DJ, Salazar-Puerta A, Moore JT, Lawrence WR, Nairon K, Francis C, Zachariah N, McCoy W, Turaga R, Skardal A, Carson WE, Higuita-Castro N, Gallego-Perez D.
Duarte-Sanmiguel S, et al. Among authors: skardal a.
Adv Healthc Mater. 2022 Mar;11(5):e2101619. doi: 10.1002/adhm.202101619. Epub 2021 Oct 27.
Adv Healthc Mater. 2022.
PMID: 34662497
Free PMC article.